Biphenyl

Biphenyl

SCHEMBL6513305

C1=NCCN1.c1ccc(-c2ccccc2)cc1

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NISCH Q9Y2I1 5/20 0.44
▸ SIGMAR1 Q99720 1/20 0.42
▸ ALDH1A1 P00352 2/20 0.41
▸ HTR2C P28335 1/20 0.41
▸ GAA P10253 2/20 0.39
▸ TSHR P16473 1/20 0.39
▸ NOTUM Q6P988 1/20 0.37
▸ KDM4E B2RXH2 1/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ RXFP1 Q9HBX9 1/20 0.36
▸ HTR7 P34969 3/20 0.36
▸ HTR1A P08908 1/20 0.36
▸ AKT1 P31749 1/20 0.35
▸ AKT2 P31751 1/20 0.35
▸ ATM Q13315 1/20 0.34
▸ ALOX15 P16050 1/20 0.34
▸ CHRNB4 P30926 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Biphenyl SCHEMBL28257729 0.92 NISCH (0.39) NISCHSIGMAR1ALDH1A1HTR2CGAA
Biphenyl SCHEMBL28257727 0.90 TSHR (0.41) NISCHSIGMAR1ALDH1A1HTR2CGAA
Benzene SCHEMBL27515431 0.85 GABRP (0.30) —
Benzene SCHEMBL27696759 0.85 GABRP (0.30) —
Pyromellitic Acid SCHEMBL6561192 0.84 ACMSD (0.41) ALDH1A1KDM4EATMALOX15
Naphthalene SCHEMBL27543353 0.84 CYP2A6 (0.38) NISCHSIGMAR1ALDH1A1HTR2CKDM4E
Benzene SCHEMBL27999450 0.83 — —
Toluene SCHEMBL28257730 0.83 LMNA (0.46) NISCHSIGMAR1HTR2CTSHRNPC1
Phenol SCHEMBL27980122 0.83 CA12 (0.46) NISCHSIGMAR1HTR2CMEN1NPC1
Aniline SCHEMBL28915575 0.81 TSHR (0.44) NISCHSIGMAR1ALDH1A1TSHRKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119350953-A Low-temperature curing powder coating for inner wall of drinking water steel pipe and preparation method and application thereof 广东华江粉末科技有限公司 2025-01-24 — — CN claimed
CN-117986239-A Irbesartan preparation method 珠海润都制药股份有限公司 2024-05-07 — — CN claimed
CN-114577971-A Method for detecting biphenyl imidazoline isomer in irbesartan 珠海润都制药股份有限公司 2022-06-03 — — CN claimed
CN-108854985-B Fiber composite adsorption material and preparation method thereof 江苏新仕力再生资源有限公司 2021-08-10 — — CN claimed
CN-111040519-A Flame-retardant powder coating and preparation method thereof 熊科 2020-04-21 — — CN claimed
CN-111040301-A Elastic stretch film and preparation method thereof 袁水清 2020-04-21 — — CN claimed
CN-110564053-A graphene wood-plastic material for furniture and preparation method thereof 韩美英 2019-12-13 — — CN claimed
CN-108840860-A The method that one kettle way prepares Irbesartan 珠海润都制药股份有限公司 2018-11-20 — — CN claimed
CN-119350953-B Low-temperature curing powder coating for inner wall of drinking water steel pipe and preparation method and application thereof 广东华江粉末科技有限公司 2025-10-10 — — CN disclosed
CN-119020930-B Anti-fading cotton spinning yarn dyeing device 豫隆纺织南通有限公司 2025-04-18 — — CN disclosed
CN-119350953-A Low-temperature curing powder coating for inner wall of drinking water steel pipe and preparation method and application thereof 广东华江粉末科技有限公司 2025-01-24 — — CN disclosed
CN-119350953-A Low-temperature curing powder coating for inner wall of drinking water steel pipe and preparation method and application thereof 广东华江粉末科技有限公司 2025-01-24 — — CN disclosed
CN-119020930-A Anti-fading cotton spinning yarn dyeing device 豫隆纺织南通有限公司 2024-11-26 — — CN disclosed
CN-117986239-A Irbesartan preparation method 珠海润都制药股份有限公司 2024-05-07 — — CN disclosed
US-20050036993-A1 Immune activation by double-stranded polynucleotides KOHN LEONARD D (US) 2005-02-17 — — US disclosed
US-20020142974-A1 IMMUNE ACTIVATION BY DOUBLE-STRANDED POLYNUCLEOTIDES SENTRON MEDICAL, INC. 2002-10-03 — — US disclosed
US-6365616-B1 TRANSPLANT REJECTION SENTRON MEDICAL, INC. 2002-04-02 — — US disclosed
EP-1112072-A2 METHIMAZOLE DERIVATIVES AND TAUTOMERIC CYCLIC THIONES TO TREAT AUTOIMMUNE DISEASES Sentron Medical, Inc. (US) 2001-07-04 — — EP disclosed
WO-2000015768-A9 IMMUNE ACTIVATION BY DOUBLE-STRANDED POLYNUCLEOTIDES KOHN LEONARD D (US) 2000-08-31 — — WO disclosed
WO-2000012175-A2 METHIMAZOLE DERIVATIVES AND TAUTOMERIC CYCLIC THIONES TO TREAT AUTOIMMUNE DISEASES SENTRON MEDICAL, INC. (US) 2000-03-09 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050036993-A1 Immune activation by double-stranded polynucleotides MICA, CD74, HLA-DRB1 NISCH 3151/4885SIGMAR1 3777/4885ALDH1A1 4712/4885
US-20020142974-A1 IMMUNE ACTIVATION BY DOUBLE-STRANDED POLYNUCLEOTIDES MICA, CD74, HLA-DRB1 NISCH 3151/4885SIGMAR1 3777/4885ALDH1A1 4712/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback